Table 1.
Author | Study population | Deadline of the study | Number of participants | Proportion of COVID-19+ patients |
Proportion of deaths on COVID-19+ patients |
||
---|---|---|---|---|---|---|---|
Severe asthma | General population | Severe asthma | General population | ||||
Hanon et al. (29) | Belgian Severe Asthma Registry | 8th July 2020 | n = 676 | 2.1% | 5.1% | 0% | 15.3%1 |
Heffler et al. (30) | Severe Asthma Network in Italy (SANI) | 19th June 2020 | n = 1504 | 1.73% | 0.39%1 | 7.7% | 14.5% |
Antonicelli et al. (31) | Italian Registry of Severe Asthma (IRSA) – until 18th May 2020 | 18th May 2020 | n = 558 | 1.25% | 0.39%1 | 0% | 14.2% |
Eger et al. (32) | Dutch Severe Asthma Registry (RAPSODI) | 30th April 2020 | n = 634 | 1.4% | 0.231 | 1.25% | 0.28% |
Rial J et al. (33) | Spanish Asthma Network (nine centers) | June 2020 | n = 545 | 6.4% | 5.2% | 0.18% | 11.13 |
1- Data not reported by the authors. Calculated using the data provided by World Health Organization (https://covid19.who.int/region/euro/country) at the time of the deadline of the study period.